We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
The Zacks Analyst Blog Highlights XLF, PPH, SPVU, INDA and DXJS
Read MoreHide Full Article
For Immediate Release
Chicago, IL – January 9, 2024 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. ETFs recently featured in the blog include: Financials - Financial Select Sector SPDR Fund (XLF - Free Report) , Healthcare - VanEck Vectors Pharmaceutical ETF (PPH - Free Report) , Value - Invesco S&P 500 Enhanced Value ETF (SPVU - Free Report) , India - iShares MSCI India ETF (INDA - Free Report) and Japan - WisdomTree Japan Hedged SmallCap Equity Fund (DXJS - Free Report) .
Here are highlights from Monday’s Analyst Blog:
5 ETF Zones Scaling New Highs at the Start of 2024
The start of 2024 has been weak for the global stock market after a blockbuster 2023. In fact. the U.S. stock market had its worst start in several decades on overbought conditions, which resulted in a cautious approach among investors and the rotation from high-performing stocks to those perceived as undervalued.
A high level of market euphoria has set the stage for a potential reversal at the start of 2024. Uncertainty about when the Fed will begin to cut rates has dampened investors' optimism. The latest Fed minutes showed that it wouldn't cut rates as aggressively as expected for this year. This suggests an uncertain path toward interest rate cuts and reflects a growing sense that inflation is under control (read: Time for Emerging Markets ETFs?).
The disappointing manufacturing data also added to the chaos. The U.S. manufacturing sector slipped further into contraction during December, according to the latest PMI data from S&P Global, as output declined and the downturn in new orders gathered pace.
Here we discuss these ETFs in detail with reasons for their strong performance.
Financials - Financial Select Sector SPDR Fund
The financial sector extended its strong rally to start 2024 on the prospect of falling interest rates, which would lower funding costs and the price of credit, thereby leading to high loan demand in the year ahead. The Financial Select Sector SPDR Fund is the ultra-popular ETF in the financial space with AUM of $34.4 billion and average daily volume of 37 million shares.
It seeks to provide exposure to 72 companies in diversified financial services, insurance, banks, capital markets, mortgage real estate investment trusts, consumer finance, and thrifts and mortgage finance industries. Financial Select Sector SPDR Fund follows the Financial Select Sector Index, charging investors 10 bps in fees per year. It carries a Zacks ETF Rank #1 (Strong Buy) with a Medium risk outlook (read: 5 Power-Packed ETFs to Buy for 2024).
Healthcare - VanEck Vectors Pharmaceutical ETF
The healthcare sector has been on a tear on the back of some sector rotation along with strength in biotechnology and pharmaceutical firms. Investors are in search of cheap stocks for their portfolios after a huge surge in 2023. Healthcare stocks didn't explode much last year amid the broad market rally. VanEck Vectors Pharmaceutical ETF follows the MVIS US Listed Pharmaceutical 25 Index, which measures the performance of companies involved in pharmaceuticals, including pharmaceutical research and development as well as production, marketing and sales of pharmaceuticals. It holds 26 stocks in its basket.
VanEck Vectors Pharmaceutical ETF has amassed $437.1 million in its asset base and trades in a good volume of about 101,000 shares a day. It charges 36 bps in annual fees and has a Zacks ETF Rank #3 (Hold) with a Medium risk outlook.
Value - Invesco S&P 500 Enhanced Value ETF
With faltering big tech and rising yields, the appeal for value investing has returned. It indicates a big reversal from 2023, where growth investing took charge. Value investing involves buying stocks that are believed to be undervalued or trading below their intrinsic worth. Invesco S&P 500 Enhanced Value ETF follows the S&P 500 Enhanced Value Index, which measures the performance of stocks in the S&P 500 Index that have the highest "value score." The product holds 101 stocks in its basket with key holdings in financials, energy and healthcare (read: Value ETFs Reach New 52-Week High to Start 2024).
Invesco S&P 500 Enhanced Value ETF has accumulated $89 million in AUM while trading in a light average daily volume of 11,000 shares. The product charges 13 bps in annual fees and has a Zacks ETF Rank #1 with a Medium risk outlook.
India - iShares MSCI India ETF
India's economy is in a good shape with robust domestic demand and strong growth in the manufacturing and services sectors. India is set be the fastest growing economy in the G20 grouping of large nations and the stocks in the country are capitalizing on this growth. iShares MSCI India ETF offers exposure to large and mid-cap companies in India by tracking the MSCI India Index and charging 65 bps in fees per year from investors.
Holding 131 stocks in its basket, the fund is highly concentrated on the top firm with near double-digit allocation. Financials dominates the fund's portfolio with 26.2% share, closely followed by information technology (12.5%), consumer discretionary (11.5%) and energy (10.4%).
iShares MSCI India ETF is the largest and the most popular ETF in this space, with AUM of $8 billion and an average trading volume of 3 million shares a day. It has a Zacks ETF Rank #3 with a Medium risk outlook.
Japan - WisdomTree Japan Hedged SmallCap Equity Fund
Japan stocks rose on a weaker yen, which spurred the buying by exporters, including automakers and financials, amid a continued hunt for value stocks. This benefited the currency-hedged ETFs in particular, as these funds look to strip out currency exposure to a foreign economy via the use of currency forwards or other instruments that bet against the non-dollar currency while offering exposure to foreign stocks.
With AUM of $53.8 million, WisdomTree Japan Hedged SmallCap Equity Fund offers exposure to the small-cap segment of Japan's equity market while hedging exposure to fluctuations between the U.S. dollar and the yen. It follows the WisdomTree Japan Hedged SmallCap Equity Index. WisdomTree Japan Hedged SmallCap Equity Fund trades in a solid volume of 40,000 shares per day and charges 58 bps in annual fees.
Want key ETF info delivered straight to your inbox?
Zacks' free Fund Newsletter will brief you on top news and analysis, as well as top-performing ETFs, each week.
Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit https://www.zacks.com/performance for information about the performance numbers displayed in this press release.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Shutterstock
The Zacks Analyst Blog Highlights XLF, PPH, SPVU, INDA and DXJS
For Immediate Release
Chicago, IL – January 9, 2024 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. ETFs recently featured in the blog include: Financials - Financial Select Sector SPDR Fund (XLF - Free Report) , Healthcare - VanEck Vectors Pharmaceutical ETF (PPH - Free Report) , Value - Invesco S&P 500 Enhanced Value ETF (SPVU - Free Report) , India - iShares MSCI India ETF (INDA - Free Report) and Japan - WisdomTree Japan Hedged SmallCap Equity Fund (DXJS - Free Report) .
Here are highlights from Monday’s Analyst Blog:
5 ETF Zones Scaling New Highs at the Start of 2024
The start of 2024 has been weak for the global stock market after a blockbuster 2023. In fact. the U.S. stock market had its worst start in several decades on overbought conditions, which resulted in a cautious approach among investors and the rotation from high-performing stocks to those perceived as undervalued.
A high level of market euphoria has set the stage for a potential reversal at the start of 2024. Uncertainty about when the Fed will begin to cut rates has dampened investors' optimism. The latest Fed minutes showed that it wouldn't cut rates as aggressively as expected for this year. This suggests an uncertain path toward interest rate cuts and reflects a growing sense that inflation is under control (read: Time for Emerging Markets ETFs?).
The disappointing manufacturing data also added to the chaos. The U.S. manufacturing sector slipped further into contraction during December, according to the latest PMI data from S&P Global, as output declined and the downturn in new orders gathered pace.
Here we discuss these ETFs in detail with reasons for their strong performance.
Financials - Financial Select Sector SPDR Fund
The financial sector extended its strong rally to start 2024 on the prospect of falling interest rates, which would lower funding costs and the price of credit, thereby leading to high loan demand in the year ahead. The Financial Select Sector SPDR Fund is the ultra-popular ETF in the financial space with AUM of $34.4 billion and average daily volume of 37 million shares.
It seeks to provide exposure to 72 companies in diversified financial services, insurance, banks, capital markets, mortgage real estate investment trusts, consumer finance, and thrifts and mortgage finance industries. Financial Select Sector SPDR Fund follows the Financial Select Sector Index, charging investors 10 bps in fees per year. It carries a Zacks ETF Rank #1 (Strong Buy) with a Medium risk outlook (read: 5 Power-Packed ETFs to Buy for 2024).
Healthcare - VanEck Vectors Pharmaceutical ETF
The healthcare sector has been on a tear on the back of some sector rotation along with strength in biotechnology and pharmaceutical firms. Investors are in search of cheap stocks for their portfolios after a huge surge in 2023. Healthcare stocks didn't explode much last year amid the broad market rally. VanEck Vectors Pharmaceutical ETF follows the MVIS US Listed Pharmaceutical 25 Index, which measures the performance of companies involved in pharmaceuticals, including pharmaceutical research and development as well as production, marketing and sales of pharmaceuticals. It holds 26 stocks in its basket.
VanEck Vectors Pharmaceutical ETF has amassed $437.1 million in its asset base and trades in a good volume of about 101,000 shares a day. It charges 36 bps in annual fees and has a Zacks ETF Rank #3 (Hold) with a Medium risk outlook.
Value - Invesco S&P 500 Enhanced Value ETF
With faltering big tech and rising yields, the appeal for value investing has returned. It indicates a big reversal from 2023, where growth investing took charge. Value investing involves buying stocks that are believed to be undervalued or trading below their intrinsic worth. Invesco S&P 500 Enhanced Value ETF follows the S&P 500 Enhanced Value Index, which measures the performance of stocks in the S&P 500 Index that have the highest "value score." The product holds 101 stocks in its basket with key holdings in financials, energy and healthcare (read: Value ETFs Reach New 52-Week High to Start 2024).
Invesco S&P 500 Enhanced Value ETF has accumulated $89 million in AUM while trading in a light average daily volume of 11,000 shares. The product charges 13 bps in annual fees and has a Zacks ETF Rank #1 with a Medium risk outlook.
India - iShares MSCI India ETF
India's economy is in a good shape with robust domestic demand and strong growth in the manufacturing and services sectors. India is set be the fastest growing economy in the G20 grouping of large nations and the stocks in the country are capitalizing on this growth. iShares MSCI India ETF offers exposure to large and mid-cap companies in India by tracking the MSCI India Index and charging 65 bps in fees per year from investors.
Holding 131 stocks in its basket, the fund is highly concentrated on the top firm with near double-digit allocation. Financials dominates the fund's portfolio with 26.2% share, closely followed by information technology (12.5%), consumer discretionary (11.5%) and energy (10.4%).
iShares MSCI India ETF is the largest and the most popular ETF in this space, with AUM of $8 billion and an average trading volume of 3 million shares a day. It has a Zacks ETF Rank #3 with a Medium risk outlook.
Japan - WisdomTree Japan Hedged SmallCap Equity Fund
Japan stocks rose on a weaker yen, which spurred the buying by exporters, including automakers and financials, amid a continued hunt for value stocks. This benefited the currency-hedged ETFs in particular, as these funds look to strip out currency exposure to a foreign economy via the use of currency forwards or other instruments that bet against the non-dollar currency while offering exposure to foreign stocks.
With AUM of $53.8 million, WisdomTree Japan Hedged SmallCap Equity Fund offers exposure to the small-cap segment of Japan's equity market while hedging exposure to fluctuations between the U.S. dollar and the yen. It follows the WisdomTree Japan Hedged SmallCap Equity Index. WisdomTree Japan Hedged SmallCap Equity Fund trades in a solid volume of 40,000 shares per day and charges 58 bps in annual fees.
Want key ETF info delivered straight to your inbox?
Zacks' free Fund Newsletter will brief you on top news and analysis, as well as top-performing ETFs, each week.
Get it free >>
Media Contact
Zacks Investment Research
800-767-3771 ext. 9339
support@zacks.com
https://www.zacks.com
Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit https://www.zacks.com/performance for information about the performance numbers displayed in this press release.